Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-022813
Filing Date
2016-06-14
Accepted
2016-06-14 17:00:28
Documents
1
Period of Report
2016-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6379
  Complete submission text file 0000899243-16-022813.txt   7973
Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address
Mills Kenneth T. (Reporting) CIK: 0001652824 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37553 | Film No.: 161713636